Global PVA Foam Embolization Particles Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global PVA Foam Embolization Particles Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
PVA Foam Embolization Particles report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global PVA Foam Embolization Particles market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Uterine Fibroid Embolization and Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for PVA Foam Embolization Particles industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, PVA Foam Embolization Particles key manufacturers include Cook Medical, Sirtex Medical, Merit Medical, BTG Medical, Boston Scientific, Terumo, HENGRUI Medical, INterface BIOmaterials and Alicon, etc. Cook Medical, Sirtex Medical, Merit Medical are top 3 players and held % sales share in total in 2022.
PVA Foam Embolization Particles can be divided into 50μm~350μm, 350μm~560μm, 560μm~710μm and 710μm~1000μm, etc. 50μm~350μm is the mainstream product in the market, accounting for % sales share globally in 2022.
PVA Foam Embolization Particles is widely used in various fields, such as Uterine Fibroid Embolization, Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH), Liver Tumor Embolization and Trauma Embolization, etc. Uterine Fibroid Embolization provides greatest supports to the PVA Foam Embolization Particles industry development. In 2022, global % sales of PVA Foam Embolization Particles went into Uterine Fibroid Embolization filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global PVA Foam Embolization Particles market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Cook Medical
Sirtex Medical
Merit Medical
BTG Medical
Boston Scientific
Terumo
HENGRUI Medical
INterface BIOmaterials
Alicon
Segment by Type
50μm~350μm
350μm~560μm
560μm~710μm
710μm~1000μm
1000μm~1400μm
1400μm~2000μm
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the PVA Foam Embolization Particles market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of PVA Foam Embolization Particles, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the PVA Foam Embolization Particles industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of PVA Foam Embolization Particles in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, PVA Foam Embolization Particles introduction, etc. PVA Foam Embolization Particles Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of PVA Foam Embolization Particles market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for PVA Foam Embolization Particles industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, PVA Foam Embolization Particles key manufacturers include Cook Medical, Sirtex Medical, Merit Medical, BTG Medical, Boston Scientific, Terumo, HENGRUI Medical, INterface BIOmaterials and Alicon, etc. Cook Medical, Sirtex Medical, Merit Medical are top 3 players and held % sales share in total in 2022.
PVA Foam Embolization Particles can be divided into 50μm~350μm, 350μm~560μm, 560μm~710μm and 710μm~1000μm, etc. 50μm~350μm is the mainstream product in the market, accounting for % sales share globally in 2022.
PVA Foam Embolization Particles is widely used in various fields, such as Uterine Fibroid Embolization, Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH), Liver Tumor Embolization and Trauma Embolization, etc. Uterine Fibroid Embolization provides greatest supports to the PVA Foam Embolization Particles industry development. In 2022, global % sales of PVA Foam Embolization Particles went into Uterine Fibroid Embolization filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global PVA Foam Embolization Particles market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Cook Medical
Sirtex Medical
Merit Medical
BTG Medical
Boston Scientific
Terumo
HENGRUI Medical
INterface BIOmaterials
Alicon
Segment by Type
50μm~350μm
350μm~560μm
560μm~710μm
710μm~1000μm
1000μm~1400μm
1400μm~2000μm
Segment by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the PVA Foam Embolization Particles market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of PVA Foam Embolization Particles, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the PVA Foam Embolization Particles industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of PVA Foam Embolization Particles in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, PVA Foam Embolization Particles introduction, etc. PVA Foam Embolization Particles Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of PVA Foam Embolization Particles market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.